Mar 16, 2025
https://www.prnewswire.com/news-releases/latigo-biotherapeutics-closes-150-million-in-series-b-financing-to-advance-non-opioid-pain-therapeutics-302397457.html
Foresite Capital Management, LLC has invested $150M in Latigo Biotherapeutics, Inc.